Literature DB >> 10702061

Respiratory distress associated with zanamivir.

J C Williamson, P S Pegram.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702061     DOI: 10.1056/NEJM200003023420914

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Use of antiviral prophylaxis in influenza outbreaks in long term care facilities.

Authors:  A McGeer; D S Sitar; S E Tamblyn; K Faron; P Orr; F Y Aoki
Journal:  Can J Infect Dis       Date:  2000-07

2.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

3.  Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism.

Authors:  Khushboo D Malbari; Anand S Chintakrindi; Lata R Ganji; Devanshi J Gohil; Sweta T Kothari; Mamata V Joshi; Meena A Kanyalkar
Journal:  Mol Divers       Date:  2019-02-01       Impact factor: 2.943

4.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Brett W Jagger; Zong-Mei Sheng; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

5.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

6.  Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.

Authors:  Michaël Schwarzinger; Bruno Housset; Fabrice Carrat
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 7.  Antivirals for influenza: what is their role in the older patient?

Authors:  Ghinwa Dumyati; Ann R Falsey
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

8.  Economic evaluations of neuraminidase inhibitors to control influenza.

Authors:  Michaël Schwarzinger; Karine Lacombe; Fabrice Carrat
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-04       Impact factor: 2.217

Review 9.  Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy.

Authors:  Daniel E Noyola
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Authors:  Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.